BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11747281)

  • 1. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG; Bayraktar F; Yilmaz C
    Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T; Schlaghecke R
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
    Kamel N; Erdoğan MF; Tonyukuk V; Ilgin SD; Erdoğan G
    Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.
    Wichers-Rother M; Grigull A; Sokolowski P; Stoffel-Wagner B; Köhler W
    J Neurol; 2005 Dec; 252(12):1525-9. PubMed ID: 16362829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
    Del Monte P; Bernasconi D; Bertolazzi L; Meozzi M; Badaracco B; Torre R; Marugo M
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):273-7. PubMed ID: 7758232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
    Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
    J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Chiarito M; Lattanzio C; D'Ascanio V; Capalbo D; Cavarzere P; Grandone A; Aiello F; Pepe G; Wasniewska M; Zoller T; Salerno M; Faienza MF
    Endocrine; 2024 May; 84(2):727-734. PubMed ID: 38536547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase are impaired in adrenal incidentalomas.
    Sadoul JL; Kézachian B; Altare S; Hadjali Y; Canivet B
    Eur J Endocrinol; 1999 Sep; 141(3):238-45. PubMed ID: 10474121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB; Chasalow FI; Blethen SL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal plasma steroid relations in glucocorticoid-naïve premenopausal rheumatoid arthritis patients during insulin-induced hypoglycemia test compared to matched normal control females.
    Imrich R; Vigas M; Rovensky J; Aldag JC; Masi AT
    Endocr Regul; 2009 Apr; 43(2):65-73. PubMed ID: 19856711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH.
    Kizildere S; Glück T; Zietz B; Schölmerich J; Straub RH
    Eur J Endocrinol; 2003 Jan; 148(1):45-53. PubMed ID: 12534357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.